Pfizer/BioNTech COVID-19 vaccine shows 90.7% efficacy in trial in children

By Michael Erman NEW YORK (Reuters) -The Pfizer/BioNTech COVID-19 vaccine showed 90.7% efficacy against the coronavirus in a clinical trial of children 5 to 11 years old, the U.S. drugmaker said on Friday. Sixteen children in the trial who had received a…

U.S. airlines, White House say vaccine mandate will not impact holiday travel

By David Shepardson and Rajesh Kumar Singh WASHINGTON/CHICAGO (Reuters) – Two major U.S. airlines and the White House said they do not think the Biden administration’s executive order mandating federal contractors require employee vaccinations by Dec. 8 will impact holiday travel or…

Children with mild COVID-19 may not develop antibodies; oral vaccine booster shows promise in monkey study

By Nancy Lapid (Reuters) – The following is a summary of some recent studies on COVID-19. They include research that warrants further study to corroborate the findings and that have yet to be certified by peer review. Children with mild COVID-19 may…

CVS to begin COVID-19 vaccine appointments in Connecticut Tomorrow

NEW HAVEN, CT— There’s good news for Connecticut residents as the COVID-19 vaccine shortage continues, CVS has announced it is receiving 81,900 doses and will start appointments on Thursday. Starting Thursday, February 11, CVS Health (NYSE: CVS) will begin to offer COVID-19…

CVS to distribute 81,900 COVID-19 vaccinations, appointments to start Tuesday

LOS ANGELES, CA — There’s good news for California residents as the COVID-19 vaccine shortage continues, CVS has announced it is receiving 81,900 doses and will start appointments on Thursday. Starting Thursday, February 11, CVS Health (NYSE: CVS) will begin to offer…